PMA device
ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia Management
Menicon Co, Ltd. · Lens, Contact, Orthokeratology, Overnight (NUU, Class III) · First FDA decision May 6, 2021, newest May 6, 2021Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "ACUVUE Abiliti"
MAUDE reports
7
Brand "ACUVUE Abiliti", since 2015
PubMed studies
0
Mentioning "ACUVUE Abiliti"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia Management
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ACUVUE® Abiliti Overnight and ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia ManagementPMA supplement
P990018-S006 · Decided May 6, 2021 · 105 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, contact, orthokeratology, overnight (NUU) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ACUVUE Abiliti", any status and sponsor, newest update first.
Johnson & Johnson Vision Care, Inc.Not on our public-company list
NCT05634408 · 75 participants · Start Dec 24, 2022 · Primary completion Aug 20, 2025
Device: ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management (A1D) · For: Visual Acuity
Sites: Qionghai, China
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ACUVUE Abiliti", and for the whole product code for context.
This brand
7 reports: 1 malfunction, 6 injury, 0 death
Whole product code NUU
40 reports: 3 malfunction, 37 injury, 0 death
Newest reports for this brand
1000188353-2026-00004 · Received Apr 22, 2026 · Event dated Mar 25, 2026
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Eye Infections; Eye Pain; Swelling/ Edema
1000188353-2025-00009 · Received Dec 23, 2025 · Event dated Oct 21, 2025
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Conjunctivitis; Corneal Scar; Corneal Ulcer; Itching Sensation; Keratitis; Red Eye(s); Excessive Tear Production; Eye Pain; Swelling/ Edema; Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Photophobia
1000188353-2025-00007 · Received Sep 4, 2025 · Event dated Aug 4, 2025
Device type: Lens, Contact, Orthokeratology, Overnight (NUU)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Corneal Scar; Corneal Ulcer; Red Eye(s); Blurred Vision; Excessive Tear Production; Eye Pain
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ACUVUE Abiliti"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NUU.
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear and Euclid Orthokeratology (tisilfocon A) ContactEuclid Vision Corporation · PMA 2026
- Boston Orthokeratology (oprifocon A) Shaping lens for Overnight Wear for Bausch + Lomb Vision Shaping TreatmentBausch & Lomb · PMA 2025
- Menicon Z Night (tisilfocon A) Contact Lenses for Overnight WearMenicon Co, Ltd. · PMA 2022
- Paragon Z CRT (tisilfocon A) and Paragon Z CRT Dual Axis (tisilfocon A) Rigid Gas Permeable Contact lenses in blue tintCooperVision, Inc. · PMA 2019
- Jsz Orthokeratology (Oprifocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2016
- DilightTM (roflufocon E) Overnight Orthokeratology Contact LensTianjin MasterVision Technology Co., Ltd. · PMA 2026
- Optimum Infinite (tisilfocon A) Orthokeratology Lenses IIContamac, Ltd. · PMA 2026
- Orthokeratology (tisilfocon A) Contact Lenses for Overnight WearEuclid Vision Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.